RenovoRx, Inc. Common Stock (RNXT)
RenovoRx, Inc. Common Stock (RNXT) has reported earnings 14 times since Nov 15, 2021. The stock moves an average of ±14.94% the day after reporting, closing higher 42.9% of the time. Its largest post-earnings gain was +98.62% (May 15, 2023) and its largest decline was -29.81% (Nov 14, 2023). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
14
Avg Abs. Movement
±14.94%
Positive %
42.9%
Negative %
57.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☽ POST | $0.84 | $0.87 | $0.87 | 736 | -6.01% | open_in_new |
| Mar 30, 2026 | ☽ POST | $1.11 | $1.11 | $1.05 | 1,183 | -2.86% | open_in_new |
| Nov 13, 2025 | ☽ POST | $0.98 | $1.00 | $0.97 | 5,518 | -22.31% | open_in_new |
| Aug 14, 2025 | ☽ POST | $1.27 | $1.29 | $1.24 | 7,946 | -22.66% | open_in_new |
| May 15, 2025 | ☽ POST | $1.06 | $1.12 | $1.12 | 7,430 | +5.8% | open_in_new |
| Nov 14, 2024 | ☀ PRE | $1.06 | $1.06 | $1.06 | 100 | -2.75% | open_in_new |
| Nov 14, 2023 | ☀ PRE | $0.73 | $0.73 | $0.73 | 202 | -29.81% | open_in_new |
| Aug 17, 2023 | ☀ PRE | $1.80 | $1.80 | $1.80 | 484 | +1.69% | open_in_new |
| May 15, 2023 | ☀ PRE | $4.33 | $4.33 | $4.33 | 0 | +98.62% | open_in_new |
| Mar 02, 2023 | ☀ PRE | $5.21 | $5.21 | $5.03 | 561 | +0.5% | open_in_new |
| Nov 14, 2022 | ☀ PRE | $1.93 | $1.93 | $1.93 | 100 | -0.52% | open_in_new |
| Aug 15, 2022 | ☀ PRE | $2.37 | $2.37 | $2.37 | 0 | +0% | open_in_new |
| Mar 30, 2022 | ☀ PRE | $3.01 | $3.01 | $3.01 | 132 | +2.56% | open_in_new |
| Nov 15, 2021 | ☽ POST | $8.01 | $8.23 | $8.06 | 7,844 | -13.03% | open_in_new |
Earnings Count
14
Total earnings in dataset
Avg Abs. Movement
±14.94%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
6 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260521 | open_in_new SEC.gov |
| 10-K/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| CORRESP | 20260423 | open_in_new SEC.gov |
| UPLOAD | 20260422 | open_in_new SEC.gov |
Frequently asked about RNXT earnings
When does RenovoRx, Inc. Common Stock report earnings next? expand_more
RenovoRx, Inc. Common Stock (RNXT)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RNXT stock move after earnings? expand_more
Over 14 reports, RNXT has moved an average of ±14.94% the session after earnings, closing higher 42.9% of the time.
What was RNXT's biggest post-earnings move? expand_more
RNXT's largest post-earnings gain on record was +98.62% on May 15, 2023, and its largest decline was -29.81% on Nov 14, 2023.
Where can I find RenovoRx, Inc. Common Stock's SEC filings? expand_more
All of RenovoRx, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right